UHS uhsinc.com: Narxning prognoz qilingan daromadga nisbati
Forward P/S koeffitsiyenti Universal Health Services kompaniyasining baholash dinamikasini aks ettiradi, uning barqarorligi psixiatriya va umumiy tibbiyotning uyg'unligiga asoslangan. 0.70 ning joriy metrika darajasi kompaniyaning yuqori talabga ega xizmatlarining yetukligini tasdiqlaydi. Biznes o'sishi masshtab iqtisodiyoti va tarmoq quvvatini optimallashtirishga tayanadi, bu esa haddan tashqari kapital xarajatlarsiz o'z mavjudligini kengaytirish imkonini beradi.
uhsinc.com (UHS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning xususiy kapitalga nisbati Universal Health Services|UHS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Universal Health Services, Inc.|UHS - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Universal Health Services Corp|UHS - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzlari Universal Health Services|Tezkor likvidlik koeffitsiyenti uhsinc.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
UHS - Sof foyda|Kutilayotgan foyda Universal Health Services|UHS - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Universal Health Services, Inc.|UHS - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Universal Health Services Corp|UHS - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|So'nggi 12 oy davomida bir aksiya uchun sof foyda Universal Health Services|UHS - Sirpanuvchi yil uchun bir aksiya uchun foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi uhsinc.com|UHS - Bu yil bir aksiya uchun sof foydaning kutilayotgan o'sishi|Keyingi yil uchun foyda o'sishi prognozi Universal Health Services
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Universal Health Services Corp UHS
Universal Health Services ishchi kuchi yetishmovchiligi va tartibga soluvchi o'zgarishlar bosimi ostida klinikalarning tarmog'ini boshqarib, kapitalizatsiyaning operatsion daromadga bo'lgan aniq bog'liqligini namoyish etmoqda. Forward P/S koeffitsiyenti kompaniyaning joriy bozor qiymatini kutilayotgan daromadlar bilan bog'laydi va bozor kelgusidagi sotuvlar uchun qancha premium to'lashga tayyorligini belgilaydi. Forward P/S multiplikatoridagi tendentsiya aktivlarning haddan tashqari yuqori baholanishi xavfini ochib beradi, bunda koeffitsiyentning tez o'sishi inqiroz paytida pozitsiyadan chiqishni qiyinlashtiradi.
Muhim raqobatchilar
Forvard P/S multiplikatori HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|FMS - Narxning prognoz qilingan daromadga nisbati|Sotuvga nisbatan forvard narx SOLV (Solventum Health)|Encompass Health (EHC) - Narxning prognoz qilingan daromadga nisbati|DVA - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|RDNT (RadNet) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Option Care|Narxning prognoz qilingan daromadga nisbati Surgery Partners Corp (SGRY)|Narxning prognoz qilingan daromadga nisbati PINC (Premier Health)|National Vision Holdings - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PGNY|Ardent Health Partners - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx SEM (Select Medical Corporation)|ASTH: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati MEDNAX (MD)|USPH (US Physical Therapy) - Forvard P/S multiplikatori|Forvard P/S multiplikatori pennantgroup.com|Narxning prognoz qilingan daromadga nisbati Organogenesis (ORGO)|Narxning prognoz qilingan daromadga nisbati NUTX (Nutex Health Inc)|Auna Health - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati SBC (SBC Medical Group Holdings)|Evolus, Inc. - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx CYH (chs.net)|SKIN (beautyhealth.com) - Forvard narx/daromad multiplikatori|MediWound - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Biote Corp|The Joint (JYNT) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori DCGO|PIII - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Gain Therapeutics GANX|Sotuvga nisbatan forvard narx EUDA|BMGL: Forvard narx/daromad multiplikatori|CLGN: Narxning prognoz qilingan daromadga nisbati|CUPR: Forvard P/S multiplikatori|CCM - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|AMS (American Shared Hospital Services) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori MEDIROM Healthcare Group Inc. (MRM)|Forvard P/S multiplikatori ALBT|DHAI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Longevity Health Holdings XAGE|Kapitalizatsiyaning kutilayotgan sotuvga nisbati newgenivf.com (NIVF)|ATIP: Forvard narx/daromad multiplikatori|CMAX - Forvard P/S multiplikatori|KDLY: Forvard P/S multiplikatori|ModivCare Corp - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Novo Integrated Sciences|SunLink Health Systems, Inc (SSY) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori BACK (IMAC Holdings)
